Regal Investment Advisors LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Regal Investment Advisors LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$346,000
+162.1%
193,450
+176.6%
0.07%
+141.4%
Q4 2018$132,000
-32.7%
69,950
+27.3%
0.03%
-29.3%
Q3 2018$196,00054,9500.04%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$68,731,00039.63%
CVI Holdings, LLC 1,367,430$2,244,0000.87%
ESSEX INVESTMENT MANAGEMENT CO LLC 875,098$1,435,0000.20%
BARD ASSOCIATES INC 87,884$144,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$894,0000.05%
HighTower Advisors, LLC 5,284,738$8,667,0000.05%
Kore Private Wealth LLC 104,366$171,0000.04%
Arcus Capital Partners, LLC 25,000$41,0000.02%
MOORE CAPITAL MANAGEMENT, LP 320,000$525,0000.01%
MATRIX ASSET ADVISORS INC/NY 26,500$43,0000.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders